T-cell leukemia
MONDO:0005525A malignant disease of the T-lymphocytes in the bone marrow, thymus, and/or blood.
Also known as: T cell leukaemia (disease), T cell leukemia (disease), leukaemia (disease) of T cell, leukemia (disease) of T cell
1992 clinical trials for this condition and its sub-types, 9 tagged with T-cell leukemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of T-cell leukemia
-
T-cell acute lymphoblastic leukemia 75 trials · 104 incl. sub-types
4 sub-types
- T-cell prolymphocytic leukemia 17 trials
- Aggressive NK-cell leukemia 11 trials
- T-cell childhood acute lymphocytic leukemia 10 trials
- Early T cell progenitor acute lymphoblastic leukemia 4 trials
-
Adult T-cell leukemia/lymphoma 31 trials
-
Engineered t cells take aim at stubborn leukemias in early trial
Disease control Recruiting nowThis early-phase study tests a new type of immune therapy for people with certain blood cancers (leukemias) that have returned or not responded to standard treatments. The therapy uses the patient's own T cells, which are modified in the lab to recognize and attack cancer cells c…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Engineered immune cells take on tough T-Cell cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called BEAM-201 for children and young adults with T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma that has come back or not responded to standard treatments. BEAM-201 uses donor-derived immune cells that are engin…
Phase 1 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New immune cell therapy takes aim at Hard-to-Treat T-Cell cancers
Disease control Recruiting nowThis early-phase trial is testing a new type of immune therapy called CD4CAR for people with T-cell lymphoma or leukemia that has come back or not responded to treatment. The therapy uses a patient's own immune cells, which are modified in a lab to recognize and attack cancer cel…
Phase 1 • Sponsor: Huda Salman • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a super steroid tame blood cancers? new trial underway
Disease control Recruiting nowThis study tests a drug called AVM0703, a very strong steroid, given as a one-time IV infusion. It aims to see if it is safe and can shrink tumors in people with certain blood cancers like lymphoma and leukemia. The trial will enroll 144 participants aged 12 and older.
Phase 1/2 • Sponsor: AVM Biotechnology Inc • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Experimental CAR T-Cell therapy targets tough leukemias
Disease control Recruiting nowThis early-phase trial is testing an experimental treatment called CART84 for people with acute myeloid leukemia (AML) or T-cell acute lymphoblastic leukemia (T-ALL) that has come back or not responded to treatment. The therapy uses a patient's own immune cells, modified in a lab…
Phase 1/2 • Sponsor: Gyala Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a cancer drug stop leukemia before it starts?
Prevention Recruiting nowThis study tests whether the drug mogamulizumab can prevent adult T-cell leukemia/lymphoma (ATL) in people infected with HTLV-1 who are at high risk. About 134 participants will receive low doses of the drug over several weeks. The goal is to see if it can reduce the virus levels…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 09:11 UTC
-
Scientists target Cancer's weak spot: redox imbalance
Knowledge-focused Recruiting nowThis study looks for new ways to kill T-cell leukemia and lymphoma cells by disrupting their internal balance of reactive oxygen species. Researchers will test drug combinations in lab-grown cells and in samples from 120 patients with resistant disease. The goal is to find treatm…
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Scientists dig into rare blood cancer to unlock better care
Knowledge-focused Recruiting nowThis study gathers information from 50 people with T-cell prolymphocytic leukemia (T-PLL), a rare and aggressive blood cancer. Researchers will look at patients' medical records, lab results, and genetic data to better understand the disease and how it responds to current treatme…
Sponsor: French Innovative Leukemia Organisation • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC